Literature DB >> 22946414

Chemotherapeutic treatment for leukemia in a bearded dragon (Pogona vitticeps).

Gwen Jankowski1, Jeffrey Sirninger, Jessica Borne, Javier G Nevarez.   

Abstract

A 4.5-yr-old, captive-bred, male bearded dragon (Pogona vitticeps) presented for lethargy, anorexia, and increased mucoid salivation with upper respiratory clicks. Diagnostics were declined and the bearded dragon was prescribed ceftazidime 20 mg/kg i.m. q 72 hr. The patient presented again 1 wk later with a marked monocytosis, heterophilia, and lymphocytosis, and a clinical diagnosis of chronic monocytic leukemia was made. Chemotherapy with cytosine arabinoside (100 mg/m2 over 48 hr i.v.) was initiated. Forty-four hours into the treatment the dragon became acutely unresponsive and died within 1 hr. Adverse effects as a result of i.v. cytosine arabinoside therapy were not identified despite previous reports suggestive that the drug induces renal failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22946414     DOI: 10.1638/2010-0150.1

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  2 in total

1.  Pax5 and CD3 immunophenotyping of lymphoma in 2 central bearded dragons.

Authors:  Tess Rooney; Alexandra K Ford; Brandon L Plattner; Margaret A Highland; David Eshar
Journal:  J Vet Diagn Invest       Date:  2022-03       Impact factor: 1.279

2.  Gross, histologic, and immunohistochemical characteristics of cutaneous chromatophoromas in captive bearded dragons.

Authors:  Colleen F Monahan; Anne Meyer; Michael M Garner; Matti Kiupel
Journal:  J Vet Diagn Invest       Date:  2021-07-02       Impact factor: 1.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.